Carregant...
Miniatura

Tipus de document

Article

Versió

Versió acceptada

Data de publicació

Llicència de publicació

cc-by-nc-nd (c) Elsevier, 2020
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/168021

Tuberculosis-HIV co-infection: Progress and challenges after two decades of global antiretroviral treatment roll-out

Títol de la revista

Director/Tutor

ISSN de la revista

Títol del volum

Resum

Despite wide antiretroviral scale-up during the past two decades resulting in declining new infections and mortality globally, HIV-associated tuberculosis remains as a major public health concern. Tuberculosis is the leading HIV-associated opportunistic infection and the main cause of death globally and, particularly, in resource-limited settings. Several challenges exist regarding diagnosis, global implementation of latent tuberculosis treatment, management of active tuberculosis, delivery of optimal patient-centered TB and HIV prevention and care in high burden countries. In this article we review the advances on pathogenesis, diagnosis, and treatment after nearly two decades of global roll-out of antiretroviral therapy and discuss the current challenges for the global control of tuberculosis-HIV co-infection.

Citació

Citació

LETANG, Emilio, ELLIS, Jayne, NAIDOO, Kogieleum, CASAS, Esther c., SÁNCHEZ, Paquita, HASSAN-MOOSA, Razia, CRESSWELL, Fiona, MIRÓ MEDA, José m. (josé maría), GARCÍA-BASTEIRO, Alberto l.. Tuberculosis-HIV co-infection: Progress and challenges after two decades of global antiretroviral treatment roll-out. _Archivos de Bronconeumologia_. 2020. Vol. 56, núm. 7, pàgs. 446-454. [consulta: 4 de febrer de 2026]. ISSN: 0300-2896. [Disponible a: https://hdl.handle.net/2445/168021]

Exportar metadades

JSON - METS

Compartir registre